[Comparative analysis of the risk factor on the clinical information of myocardial revascularization combined with

Jun-sheng Mu1, Jian-qun Zhang, Ping Bo

  • 1Department of Cardiac Surgery, Affiliated Anzhen Hospital of Capital University of Medical Sciences, Beijing 100029, China. wesleymu@hotmail.com

Insights

Coronary artery bypass grafting (CABG) combined with valve surgery is safe. However, female patients face higher morbidity and mortality risks, linked to lower weight and mitral valve stenosis.

Area of Science:

  • Cardiovascular Surgery
  • Thoracic Surgery
  • Surgical Outcomes

Context:

  • Combined coronary artery bypass grafting (CABG) and valve operations are complex procedures.
  • Understanding sex-based differences in outcomes is crucial for patient management.

Purpose:

  • To evaluate clinical information and outcomes of patients undergoing combined CABG and valve surgery.
  • To identify potential risk factors influencing morbidity and mortality in this patient cohort.

Summary:

  • A retrospective analysis of 126 patients revealed significant differences in clinical characteristics between sexes, including weight, diabetes, mitral valve stenosis, and coronary artery disease severity.
  • Morbidity and mortality rates, as well as the number of bypass grafts and mitral valve replacements, showed significant sex-based variations.
  • Female patients experienced higher rates of complications and mortality, with specific causes including heart failure, arrhythmia, and organ failure.

Impact:

  • Female gender emerged as an independent risk factor for increased morbidity and mortality post-surgery.
  • Lower body weight and the presence of mitral valve stenosis in females contribute to adverse outcomes.
  • Findings underscore the need for tailored perioperative strategies for female patients undergoing combined cardiac procedures.
Abstract

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...